{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:38:10Z","timestamp":1760236690220,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11010-025-05332-w","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:43:59Z","timestamp":1749642239000},"page":"5447-5457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow mesenchymal stem cells promote the recovery of stroke in rats with type 2 diabetes mellitus by inhibiting the activation of TLR4\/NF-\u03baB signaling pathway"],"prefix":"10.1007","volume":"480","author":[{"given":"Fan","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taolin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"7","key":"5332_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR et al (2018) Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health 21(7):881\u2013890","journal-title":"Value Health"},{"issue":"3","key":"5332_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2015-1137","volume":"37","author":"A Kautzky-Willer","year":"2016","unstructured":"Kautzky-Willer A, Harreiter J, Pacini G (2016) Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 37(3):278\u2013316","journal-title":"Endocr Rev"},{"issue":"1","key":"5332_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR et al (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol 17(1):83","journal-title":"Cardiovasc Diabetol"},{"key":"5332_CR4","doi-asserted-by":"publisher","first-page":"154910","DOI":"10.1016\/j.metabol.2021.154910","volume":"125","author":"SS Jankauskas","year":"2021","unstructured":"Jankauskas SS et al (2021) Heart failure in diabetes. Metabolism 125:154910","journal-title":"Metabolism"},{"issue":"4","key":"5332_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT et al (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8(4):325\u2013336","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5332_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"CX Ma","year":"2022","unstructured":"Ma CX et al (2022) Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol 21(1):74","journal-title":"Cardiovasc Diabetol"},{"key":"5332_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12051102","author":"IH Vieira","year":"2024","unstructured":"Vieira IH et al (2024) Diabetes and stroke: impact of novel therapies for the treatment of type 2 diabetes mellitus. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12051102","journal-title":"Biomedicines"},{"issue":"1","key":"5332_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12933-022-01704-4","volume":"21","author":"D Liu","year":"2022","unstructured":"Liu D et al (2022) Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus. Cardiovasc Diabetol 21(1):280\u2013314","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"5332_CR9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s13300-021-01024-y","volume":"12","author":"M Gabler","year":"2021","unstructured":"Gabler M et al (2021) Guideline adherence and associated outcomes in the treatment of type 2 diabetes mellitus patients with an incident cardiovascular comorbidity: an analysis based on a large german claims dataset. Diabetes Ther 12(4):1209\u20131226","journal-title":"Diabetes Ther"},{"issue":"1","key":"5332_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12933-021-01366-8","volume":"20","author":"D Giugliano","year":"2021","unstructured":"Giugliano D et al (2021) GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs. Cardiovasc Diabetol 20(1):189","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"5332_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/cdd.2015.168","volume":"23","author":"Q Chen","year":"2016","unstructured":"Chen Q et al (2016) Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ 23(7):1128\u20131139","journal-title":"Cell Death Differ"},{"key":"5332_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biomaterials.2018.06.026","volume":"203","author":"H Lin","year":"2019","unstructured":"Lin H et al (2019) Bone marrow mesenchymal stem cells: aging and tissue engineering applications to enhance bone healing. Biomaterials 203:96\u2013110","journal-title":"Biomaterials"},{"issue":"5","key":"5332_CR13","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3390\/ijms22052410","volume":"22","author":"H Jo","year":"2021","unstructured":"Jo H et al (2021) Applications of mesenchymal stem cells in skin regeneration and rejuvenation. Int J Mol Sci 22(5):2410","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5332_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan T, Luo M, Wei X (2021) Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol 14(1):195","journal-title":"J Hematol Oncol"},{"issue":"5","key":"5332_CR15","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.3390\/ijms23052550","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Mesenchymal stem cells: therapeutic mechanisms for stroke. Int J Mol Sci 23(5):2550","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5332_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41401-023-01061-2","volume":"44","author":"J Fang","year":"2023","unstructured":"Fang J, Wang Z, Miao CY (2023) Angiogenesis after ischemic stroke. Acta Pharmacol Sin 44(7):1305\u20131321","journal-title":"Acta Pharmacol Sin"},{"key":"5332_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2016.02.058","volume":"324","author":"J Hu","year":"2016","unstructured":"Hu J et al (2016) Bone marrow stromal cells inhibits HMGB1-mediated inflammation after stroke in type 2 diabetic rats. Neuroscience 324:11\u201319","journal-title":"Neuroscience"},{"issue":"11","key":"5332_CR18","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/STROKEAHA.116.014686","volume":"47","author":"T Yan","year":"2016","unstructured":"Yan T et al (2016) Neurorestorative responses to delayed human mesenchymal stromal cells treatment of stroke in type 2 diabetic rats. Stroke 47(11):2850\u20132858","journal-title":"Stroke"},{"issue":"1","key":"5332_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13287-019-1419-2","volume":"10","author":"J Fang","year":"2019","unstructured":"Fang J et al (2019) Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1\/2-p90(rsk)-CREB pathway. Stem Cell Res Ther 10(1):312","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5332_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nbd.2012.01.001","volume":"46","author":"T Yan","year":"2012","unstructured":"Yan T et al (2012) Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiol Dis 46(1):157\u2013164","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5332_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12974-022-02651-3","volume":"19","author":"J Yan","year":"2022","unstructured":"Yan J et al (2022) TREM2 activation alleviates neural damage via Akt\/CREB\/BDNF signalling after traumatic brain injury in mice. J Neuroinflammation 19(1):289\u2013289","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5332_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q et al (2024) NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5332_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/17474930231207777","volume":"19","author":"A Zietz","year":"2024","unstructured":"Zietz A et al (2024) Targeting inflammation to reduce recurrent stroke. Int J Stroke 19(4):379\u2013387","journal-title":"Int J Stroke"},{"issue":"7","key":"5332_CR24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK et al (2016) Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study. Stroke 47(7):1817\u20131824","journal-title":"Stroke"},{"issue":"12","key":"5332_CR25","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.4252\/wjsc.v13.i12.1905","volume":"13","author":"LN Zhao","year":"2021","unstructured":"Zhao LN et al (2021) Bone marrow mesenchymal stem cell therapy regulates gut microbiota to improve post-stroke neurological function recovery in rats. World J Stem Cells 13(12):1905\u20131917","journal-title":"World J Stem Cells"},{"issue":"2","key":"5332_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.15283\/ijsc21136","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Effects and mechanisms of bone marrow mesenchymal stem cell transplantation for treatment of ischemic stroke in hypertensive rats. Int J Stem Cells 15(2):217\u2013226","journal-title":"Int J Stem Cells"},{"issue":"6","key":"5332_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.4103\/1673-5374.358609","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) Overexpression of vascular endothelial growth factor enhances the neuroprotective effects of bone marrow mesenchymal stem cell transplantation in ischemic stroke. Neural Regen Res 18(6):1286\u20131292","journal-title":"Neural Regen Res"},{"issue":"1","key":"5332_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-018-1153-1","volume":"15","author":"Z Cheng","year":"2018","unstructured":"Cheng Z et al (2018) Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation 15(1):135","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5332_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nbd.2012.03.002","volume":"46","author":"L Wei","year":"2012","unstructured":"Wei L et al (2012) Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46(3):635\u2013645","journal-title":"Neurobiol Dis"},{"issue":"2","key":"5332_CR30","doi-asserted-by":"publisher","first-page":"e0149147","DOI":"10.1371\/journal.pone.0149147","volume":"11","author":"G Ding","year":"2016","unstructured":"Ding G et al (2016) Cell treatment for stroke in type two diabetic rats improves vascular permeability measured by MRI. PLoS ONE 11(2):e0149147","journal-title":"PLoS ONE"},{"key":"5332_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2017.02.040","volume":"644","author":"J Xiang","year":"2017","unstructured":"Xiang J et al (2017) Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats. Neurosci Lett 644:62\u201366","journal-title":"Neurosci Lett"},{"key":"5332_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136939","author":"C Yu","year":"2022","unstructured":"Yu C et al (2022) Pharmacological effects of polyphenol phytochemicals on the intestinal inflammation via targeting TLR4\/NF-kappaB signaling pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23136939","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5332_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12967-022-03866-x","volume":"21","author":"X Zhang","year":"2023","unstructured":"Zhang X et al (2023) beta-glucan protects against necrotizing enterocolitis in mice by inhibiting intestinal inflammation, improving the gut barrier, and modulating gut microbiota. J Transl Med 21(1):14","journal-title":"J Transl Med"},{"issue":"2","key":"5332_CR34","doi-asserted-by":"publisher","first-page":"e0112722","DOI":"10.1128\/msystems.01127-22","volume":"8","author":"Y Kang","year":"2023","unstructured":"Kang Y et al (2023) A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver axis and inhibiting the hepatic TLR4\/NF-kappaB\/NLRP3 signaling pathway. mSystems 8(2):e0112722","journal-title":"mSystems"},{"issue":"22","key":"5332_CR35","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1111\/bph.15261","volume":"177","author":"X Xu","year":"2020","unstructured":"Xu X et al (2020) Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1\/TLR4\/NF-kappaB and TNF-alpha\/TNFR1\/NF-kappaB pathways. Br J Pharmacol 177(22):5224\u20135245","journal-title":"Br J Pharmacol"},{"issue":"12","key":"5332_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/jcmm.17758","volume":"27","author":"Y Xu","year":"2023","unstructured":"Xu Y et al (2023) Engeletin alleviates cerebral ischemia reperfusion-induced neuroinflammation via the HMGB1\/TLR4\/NF-kappaB network. J Cell Mol Med 27(12):1653\u20131663","journal-title":"J Cell Mol Med"},{"issue":"9","key":"5332_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/aps.2017.22","volume":"38","author":"N Pan","year":"2017","unstructured":"Pan N et al (2017) Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS\/TLR4\/NF-\u03baB inflammatory signaling pathway. Acta Pharmacol Sin 38(9):1236\u20131247","journal-title":"Acta Pharmacol Sin"},{"issue":"1\u20132","key":"5332_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11481-022-10051-w","volume":"18","author":"WC Yang","year":"2023","unstructured":"Yang WC et al (2023) Molecular hydrogen mediates neurorestorative effects after stroke in diabetic rats: the TLR4\/NF-kappaB inflammatory pathway. J Neuroimmune Pharmacol 18(1\u20132):90\u201399","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05332-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05332-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05332-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:47:52Z","timestamp":1760168872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05332-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5332"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05332-w","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of relevant guidelines and regulations. Approval was granted by the Ethics Committee of the Second Affiliated Hospital of Hunan Normal University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}